Aardvark says FDA lifted clinical hold on ARD-101 for Prader-Willi hyperphagiaNov 13Quarterly updateAardvark Therapeutics, Inc.ARD-101
Harmony Biosciences posts Q3 results, highlights BP-205 safety dataNov 4Quarterly updateAni Pharmaceuticals IncHarmony Biosciences Holdings, Inc.
Pfizer raises 2026 guidance after Q3, reports pipeline progress and new CFONov 3Quarterly updateBioNTech SEC4 Therapeutics, Inc.
Takeda registers observational RETRACE study on real-world narcolepsy type 1 treatment patternsOct 29Trial updateTakeda Pharmaceutical Co Ltd
Aardvark reports exploratory HERO and OLE data for ARD-101 in Prader-Willi syndromeOct 23Clinical readoutAardvark Therapeutics, Inc.ARD-101
Harmony Biosciences names Peter Anastasiou CEO, succeeding Jeffrey DaynoOct 13PeopleHarmony Biosciences Holdings, Inc.pitolisant
Harmony Biosciences reports record WAKIX revenue, posts Phase 1 data for BP-205Aug 4Quarterly updateHarmony Biosciences Holdings, Inc.pitolisant
Harmony Biosciences preannounces record Q2 2026 revenue, CFO steps downJul 16PeopleHarmony Biosciences Holdings, Inc.pitolisant